Professor Farber to FCC
Internet pioneer David Farber, the Alfred Fitler Moore Professor of Telecommunication
Systems, has been named Chief Technologist for the Federal Communications
Commission (FCC). He will be on leave while in the government service in
Washington. The position is traditionally a one- or two-year appointment
held by a scholar. Professor Faber said that while he will not be teaching
he will remain on some key committees and still advise his graduate students.
"This appointment identifies Dave as the country's foremost expert
in telecommunication technology. We are all delighted," said Dean Eduardo
William Kennard, chairman of the FCC, welcomed Professor Farber noting,
"The FCC, and, indeed, the entire country, are very fortunate to have
the services of such a distinguished, world-class technology expert as Dave
Farber at this time, as the FCC continues to tackle the complicated and
increasingly technical issues involved in ensuring universal broadband access."
A Fellow of the IEEE and the holder of the 1995 SIGCOMM Award for lifelong
contributions to the field, Professor Farber has been the director of both
the Center for Communications & Information Science & Policy and
the Laboratory for Distributed Systems at Penn where he has led research
in ultra-high speed networking, the design of innovative distributed computer
architecture and distributed collaboration methodology.
MLK Celebration: January 17
To the University Community:
The theme for this year's celebration of the birth of Dr. Martin Luther
King, Jr. is The Importance of King's Philosophy and Action for the 21st
We encourage all faculty, staff and students to participate in some of
the many commemorative
programs being held between January 17 and January 28.
Release time has been authorized for staff to attend Martin Luther King,
Jr. Day commemorative programs on January 17, and supervisors are encouraged
to be flexible in granting release time and making arrangements for coverage
Likewise, faculty are encouraged to be flexible regarding class attendance
to allow students the opportunity to participate fully in January 17 programming.
--Judith Rodin, President
--Robert Barchi, Provost
--John Fry, Executive Vice President
New Vice President Finance & Treasurer
Craig Carnaroli, director of the Health Care Finance Department at Merrill
Lynch & Co., has been named Vice President for Finance and Treasurer
at Penn by Executive Vice President John A. Fry.
As Vice President for Finance and Treasurer, Mr. Carnaroli is responsible
for the University's financial planning processes and coordinates the financial
activities for the University and its component parts. He is directly responsible
for the offices of the Comptroller, Treasurer, Investments, Student Financial
Services, Risk Management, Research Services and Acquisition Services.
"Craig is an outstanding financial executive, who has spent his
entire career in public finance investment banking, working primarily with
hospitals and colleges and universities," said Mr. Fry. "His expertise
in these areas will enable him to lead the Division of Finance forward in
a strategic and progressive manner, as well as enable him to play a key
role in planning financial strategies for the University and the Health
Mr. Carnaroli joined Merrill Lynch in 1995, where he led a team of professionals
responsible for structuring and marketing tax-exempt and taxable debt issues
for non-profit education and healthcare institutions. During the course
of his investment banking career, Mr. Carnaroli raised over $5 billion of
capital for non-profit institutions. His accomplishments include the implementation
of a debt recapitalization for an academic health system, the introduction
of a new credit to the capital markets through the formation of an obligated
group comprised of community-based Catholic hospitals, and development of
a rating agency strategy resulting in the first "Aaa/AAA" rating
for a private secondary school.For the past year, he has been advising the
University and its Health System on a broad range of financial strategy,
rating agency and institutional investor relations issues.
Mr. Carnaroli came to Merrill Lynch from CS First Boston, where he had
served most recently as Vice President, Municipal Securities Division. While
at CS First Boston, he assisted the University in the development of the
Health System's borrowing structure through the development of the Master
Trust Indenture. He joined CS First Boston in 1985.
He received a B.S. in Economics cum laude from the Wharton School, and
an M.B.A. from the Stanford University Graduate School of Business.
Mr. Fry said Mr. Carnaroli's appointment is expected to be approved by
Penn's Board of Trustees at its Stated Meeting in February.
$6.5 Million for Center of Excellence
for Autoimmune Disease
The Medical Center has received a five-year $6.5 million grant from the
National Institutes of Health (NIH) to establish the new Penn Center of
Excellence for Autoimmune Disease.
"Our goal for the center is to try to translate knowledge from basic
science into clinical practice, focusing first on multiple sclerosis (MS)
and systemic lupus erythematosus (SLE)," said Dr. Mohamad Rostami,
professor of neurology and director of the new center. Dr. Rostami and the
rest of the center's investigators will use animal models to learn how these
diseases are produced and ultimately, how to treat them. The final step
will be attempting to bridge treatment from animal to human studies.
Dr. Rostami is currently the principal investigator of a study to prevent
the relapse of MS by neutralizing interleukin-12 with antibodies. According
to Dr. Rostami, "we have been able to prevent relapses in the mice
with EAE using antibodies interleukin-12 for the first time. Most treatments
for MS are first tried out in the experimental EAE model before being tested
in humans. This research, therefore, represents another possible therapy
for MS patients." The study, which was originally successful with mouse
models, will soon include human MS patients.
Dr. Robert A. Eisenberg, professor of medicine and neurology, is the
principal investigator of the SLE study, which involves destroying pathogenic
B cells. Dr. Eisenberg's general research interests are cellular, biochemical,
and genetic mechanisms of systemic autoimmunity.
Other faculty members of the Center of Excellence for Autoimmune Disease
include: Dr. Daniel A. Albert, associate professor of medicine; Dr. Phillip
Cohen, professor of medicine; Dr. Steven L. Galetta, professor of neurology;
Dr. Malek Kamoun, professor of pathology and laboratory medicine; and Dr.
Burton Zweiman, emeritus professor of medicine and neurology.